PRILENAP HL
Tablet, 10mg + 12.5mg
RxActive license
Active substance (INN)
enalaprilhydrochlorothiazide
Pharmaceutical form
Pharmaceutical formTablet
Strength10mg + 12.5mg
PackagingUkupno 30 tableta u blisteru (3x10) u kartonskoj kutiji
ManufacturerHemofarm a.d. Vršac, Serbia
Therapeutic groupCardiovascular system (C09BA02)
Marketing authorization holderDRUŠTVO SA OGRANIČENOM ODGOVORNOŠĆU "HEMOMONT" ZA PROIZVODNJU FARMACEUTSKIH PROIZVODA PODGORICA
Authorization dateFebruary 8, 2024
Analogs in Montenegro
20Other medicines with the same active substance
AMPRIL HDRx
Tablet, 5mg + 25mgAMPRIL HLRx
Tablet, 2.5mg + 12.5mgCO-DIOVANRx
Film-coated tablet, 80mg + 12.5mgENAPRx
Tablet, 5mgENAP-HRx
Tablet, 10mg + 25mgENAP®Rx
Tablet, 10 mgENAP®Rx
Tablet, 20 mgFLIRKANORx
Film-coated tablet, 320mg + 10mg + 25mgFLIRKANORx
Film-coated tablet, 160mg + 10mg + 25mgFLIRKANORx
Film-coated tablet, 160mg + 10mg + 12.5mgFLIRKANORx
Film-coated tablet, 160mg + 5mg + 12.5mgFLIRKANORx
Film-coated tablet, 160mg + 5mg + 25mgIRBENIDA PLUSRx
Film-coated tablet, 300mg/12.5mgIRBENIDA PLUSRx
Film-coated tablet, 150mg/12.5mgIRUZIDRx
Tablet, 10mg + 12.5mgIRUZIDRx
Tablet, 20mg + 12.5mgLODOZRx
Film-coated tablet, 5mg + 6.25mgLODOZRx
Film-coated tablet, 10mg + 6.25mgLODOZRx
Film-coated tablet, 2.5mg + 6.25mgLOPRIL HRx
Tablet, 20mg + 12.5mgSource: CInMED register